Transseptal Solutions

Integrated Transseptal System

Health Tech & Life Sciences
Active
Mature Netanya, Israel Founded 2013
Last updated 2026-06-18
Total raised
Stage
Mature
Founded
2013
Headcount
2
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences

About

Transseptal Solutions, in collaboration with clinicians, researchers, and scientists worldwide, is developing a steerable sheath using a novel approach of transseptal puncture and left atrium navigation, all in one system. Transseptal Solutions seeks to improve left-atrium-access procedures and generate an approach for the expanding indications of left-heart treatments. The company's CE-marked and FDA-approved TSP Crosser is an integrated transseptal system that includes a method to engage the fossa ovalis precisely and efficiently using an extendable radiopaque loop wire and a steerable sheath. The system can precisely navigate a flexible needle for accurate and optimal left-atrium access. After the puncture, the steerable sheath serves as a guiding catheter for left-side procedures, including transcatheter mitral repair/replacement, PVL closure, atrial fibrillation ablation, and left-atrial appendage occlusion.

Q&A

What is Transseptal Solutions' primary focus?
Transseptal Solutions is developing an integrated transseptal system, the TSP Crosser, designed to improve left-atrium-access procedures using a steerable sheath and a novel approach to transseptal puncture and left atrium navigation.
When was Transseptal Solutions founded?
Transseptal Solutions was founded in November 2013.
What is the current employee count for Transseptal Solutions?
Transseptal Solutions currently has 1-10 employees.
Has Transseptal Solutions' product received regulatory approvals?
Yes, Transseptal Solutions' TSP Crosser system is CE-marked and FDA-approved.
What procedures can Transseptal Solutions' steerable sheath be used for?
After puncture, the steerable sheath from Transseptal Solutions can serve as a guiding catheter for left-side procedures, including transcatheter mitral repair/replacement, PVL closure, atrial fibrillation ablation, and left-atrial appendage occlusion.
Who are the key executives at Transseptal Solutions?
The key executives at Transseptal Solutions include Elad Sapir as CEO and Eyal Teichman as CTO.
What is Transseptal Solutions' primary sector classification?
Transseptal Solutions is primarily classified under Health Tech & Life Sciences.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

cardiologymedical-technologiesvalvessurgeonsmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)